Download

Download Full Text (610 KB)

Contents

  • New Gene Therapy for Bladder Cancer Shows Promise: A gene therapy that stimulates interferon production within the body may prove to be effective against high-risk, early-stage bladder cancer when standard treatment fails.
  • Vaccine Helps T Cells Target Sarcomas, Melanomas and other Tumors: A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is the subject of two ongoing clinical trials,
  • INBRIEF: Glypican-1 Shows Promise as a Biomarker for Pancreatic Cancer/Stereotactic Ablative Radiation Therapy for Stage I Non-Small Cell Lung Cancer May Offer Survival Benefit
  • HOUSE CALL: Prostate Cancer Screening-Who should get screened and when

Publication Date

8-1-2015

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Dinney, Colin; Benedict, William; McConkey, David; Wu, Xifeng; Somaiah, Neeta; Kalluri, Raghu; Chang, Joe Y.; Urinary Bladder Neoplasms; Genetic Therapy; Mycobacterium bovis; Interferon alpha-2; Synapsins; Cancer Vaccines; Sarcoma; Melanoma; Clinical Trials as Topic; Natural Killer T-Cells; Clinical Trials as Topic; Dendritic Cells; Pancreatic Neoplasms; Glypicans; Carcinoma, Non-Small-Cell Lung; Radiosurgery; Prostatic Neoplasms -- prevention & control; Prostate-Specific Antigen; Cancer Survivors.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Redacted

OncoLog, Volume 60, Number 08, August 2015

Share

COinS